Comparison
Abeta Amyloidosis Dutch Type C2931672 vs 2 Hydroxyglutaric Aciduria C2746066
Clinical comparison between Abeta Amyloidosis Dutch Type and 2 Hydroxyglutaric Aciduria for differential diagnosis and treatment planning.
Abeta Amyloidosis Dutch Type C2931672
Hereditary cerebral amyloid angiopathy from APP gene mutation. Family-linked condition. Can cause brain hemorrhage and stroke.
2 Hydroxyglutaric Aciduria C2746066
An organic acidemia where elevated acids accumulate in the body. It can cause neurological and developmental problems. Treatment focuses on supportive care and symptom management.
6 comparison axes
Onset
Abeta Amyloidosis Dutch Type C2931672
45-65
2 Hydroxyglutaric Aciduria C2746066
0-10
Onset patterns differ
Severity
Abeta Amyloidosis Dutch Type C2931672
severe
2 Hydroxyglutaric Aciduria C2746066
moderate
Different severity levels
Chronic
Abeta Amyloidosis Dutch Type C2931672
Chronic
2 Hydroxyglutaric Aciduria C2746066
Chronic
Differing course
Communicable
Abeta Amyloidosis Dutch Type C2931672
No
2 Hydroxyglutaric Aciduria C2746066
No
Different transmission
Body System
Abeta Amyloidosis Dutch Type C2931672
neurologic
2 Hydroxyglutaric Aciduria C2746066
metabolic
Same/different system
Category
Abeta Amyloidosis Dutch Type C2931672
rare-disease
2 Hydroxyglutaric Aciduria C2746066
metabolic
Different category
Bottom line
abeta-amyloidosis-dutch-type-C2931672 and 2-hydroxyglutaric-aciduria-C2746066 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abeta Amyloidosis Dutch Type C2931672 | 2 Hydroxyglutaric Aciduria C2746066 | Discriminating power |
|---|---|---|---|
| Age at first concern | Typically middle adulthood, often ages 45–65 | Usually infancy or childhood, ages 0–10 | High |
| Dominant clinical pattern | Recurrent brain hemorrhage, stroke, or cognitive decline | Developmental delay and other neurologic problems | High |
| Family and metabolic context | Family-linked APP-related cerebral amyloid angiopathy | Organic acid accumulation rather than vascular amyloid | Moderate |
When to favor each condition
Choose Abeta Amyloidosis Dutch Type C2931672 when
Adult with recurrent lobar hemorrhage
This pattern fits hereditary cerebral amyloid angiopathy better than childhood aciduria
High
Family history of midlife stroke or dementia
Supports consideration of an APP-related hereditary condition
Moderate
No childhood metabolic or developmental history
Makes early-onset organic acidemia less likely, but does not prove the diagnosis
Low
Choose 2 Hydroxyglutaric Aciduria C2746066 when
Infant or child with developmental concerns
Early onset aligns with the supplied pattern for 2-hydroxyglutaric aciduria
High
Suspected organic acidemia
Metabolic evaluation is more relevant than amyloid-angiopathy testing
Moderate
Neurologic disease without adult hemorrhage
May favor a metabolic disorder, but clinician review is required
Low
How key tests differ
| Test | Abeta Amyloidosis Dutch Type C2931672 | 2 Hydroxyglutaric Aciduria C2746066 | Interpretation |
|---|---|---|---|
| Brain imaging | May show hemorrhage or other cerebrovascular injury | May show nonspecific neurologic changes; pattern is not established here | Imaging supports localization but does not by itself diagnose either condition |
| Genetic testing | APP-related variant may be sought when clinically appropriate | A relevant metabolic-gene finding may be considered | Results require specialist interpretation and do not replace clinical assessment |
| Organic acid testing | Not expected to define this vascular condition | May show elevated 2-hydroxyglutaric acid; no cutoff is supplied | An abnormal metabolite result is not automatically a complete diagnosis |
Prognosis comparison
Abeta Amyloidosis Dutch Type C2931672
- Outcome
- Potentially severe chronic neurologic disease with hemorrhage or stroke risk
- Factors
- Age, bleeding events, cognitive change, and confirmed genetic findings
2 Hydroxyglutaric Aciduria C2746066
- Outcome
- Often chronic neurologic or developmental disease managed supportively
- Factors
- Age at onset, developmental impact, metabolic control, and complications
Time frame: Both are described as chronic; exact survival is not established
Prognosis is individualized and source data do not support exact outcomes
Complications comparison
| Complication | Presentation |
|---|---|
| Stroke or brain hemorrhage | A recognized possible complication Not established from the supplied description Urgent neurologic assessment is needed for sudden deficits |
| Cognitive or developmental impairment | Cognitive decline may occur in adults Developmental problems may occur in children Severity and course vary and are not fully established here |
| Long-term disability | Severe chronic neurologic effects are possible Moderate chronic effects may require supportive care Individual prognosis should not be inferred from category alone |
Patient education highlights
- HighEmergency symptoms
Sudden weakness, speech change, severe headache, seizure, or reduced consciousness needs urgent care.
- HighDiagnosis boundaries
An imaging or laboratory abnormality is not the same as a confirmed diagnosis.
- MediumCare planning
Ask clinicians about genetic counseling, metabolic follow-up, rehabilitation, and supportive care as relevant.